Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
Pharmaceutical Technology on MSN
JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery
The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery and ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Under an alliance framework with AstraZeneca, Merck, and Eli Lilly and Company leading as founding participants, the Atlas is ...
AI Impact explores why AI security has outgrown human oversight, plus pricing gains, health care insight and key AI moves in ...
A new study published in Ecology Letters has uncovered the mechanisms underlying plant community assembly and biodiversity ...
LAHORE: Artificial intelligence (AI) is enabling researchers to uncover new cancer applications for widely used medicines by ...
Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...
Meta-analysis shows diabetes increases male infertility risk, with inflammation identified as a key underlying mechanism.
Morning Overview on MSN
Aging immune cells may edit their own DNA to stay inflamed
As people grow older, their immune systems do not simply slow down, they often become locked into a simmering, self-perpetuating state of inflammation. Emerging work now suggests that aging immune ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果